SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form ARS - Annual Report to Security Holders:
SEC Accession No. 0001193125-24-102892
Filing Date
2024-04-19
Accepted
2024-04-19 16:13:58
Documents
1
Period of Report
2023-12-31
Effectiveness Date
2024-04-19

Document Format Files

Seq Description Document Type Size
1 ARS d769294dars.pdf ARS 892302
  Complete submission text file 0001193125-24-102892.txt   1229922
Mailing Address 4224 CAMPUS POINT COURT SUITE 210 SAN DIEGO CA 92121
Business Address 4224 CAMPUS POINT COURT SUITE 210 SAN DIEGO CA 92121 858-202-6300
Regulus Therapeutics Inc. (Filer) CIK: 0001505512 (see all company filings)

IRS No.: 264738379 | State of Incorp.: DE | Fiscal Year End: 1231
Type: ARS | Act: 34 | File No.: 001-35670 | Film No.: 24857905
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)